- 33.2k views
Postponing Menopause and extending the Life of the Fertile Female
Ovarian tissue cryopreservation and autotransplantation can restore ovarian endocrine function and fertility and recently were changed from experimental to fertility preservation procedures for medical indications by the American Society of Reproductive Medicine. Such advances have resulted in discussions around the utility of ovarian cryopreservation in healthy women to preserve fertility and delay menopause or as a hormone replacement approach. Such ‘elective’ use of ovarian tissue cryopreservation requires a risk-benefit assessment. Here, we review evidence for and against the utility of ovarian tissue harvesting in healthy women, scrutinize recent and needed advances to enhance the feasibility of such an approach, and provide practice and future research guidelines as this elective procedure may not be ready for prime time just yet.
About the Speaker
DR. ABDELMONEM AWAD M. HEGAZY
Professor of Embryology at MUST, Faculty of Medicine, Zagazig University,Surgeon & Consultant Obg & Gyn, Egypt.
Watch Next
Fetal Medicine Cases, Spot the Diagnosis & Management
Primary Amenorrhea: The Importance of Early Diagnosis
Pelvic Lymph Node Assessment in Gynecological Cancer
Non-invasion Treatments in Aesthetic Functional Gynecology – An Overview
Intrahepatic Cholestasis in Pregnancy: An Overview and Update
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
DR. ABDELMONEM AWAD M. HEGAZY's Talks on Assimilate
- 17th-October-2022, TIME : 5:00PM - 6:00PM
- 0
Ovarian tissue cryopreservation and autotransplantation can restore ovarian endocrine function and fertility and recently were changed from experimental to fertility preservation procedures for medical indications by the American Society of Reproductive Medicine. Such advances have resulted in discussions around the utility of ovarian cryopreservation in healthy women to preserve fertility and delay menopause or as a hormone replacement approach. Such ‘elective’ use of ovarian tissue cryopreservation requires a risk-benefit assessment. Here, we review evidence for and against the utility of ovarian tissue harvesting in healthy women, scrutinize recent and needed advances to enhance the feasibility of such an approach, and provide practice and future research guidelines as this elective procedure may not be ready for prime time just yet.
- 17th-October-2022, TIME : 5:00PM - 6:00PM
- 0
Ovarian tissue cryopreservation and autotransplantation can restore ovarian endocrine function and fertility and recently were changed from experimental to fertility preservation procedures for medical indications by the American Society of Reproductive Medicine. Such advances have resulted in discussions around the utility of ovarian cryopreservation in healthy women to preserve fertility and delay menopause or as a hormone replacement approach. Such ‘elective’ use of ovarian tissue cryopreservation requires a risk-benefit assessment. Here, we review evidence for and against the utility of ovarian tissue harvesting in healthy women, scrutinize recent and needed advances to enhance the feasibility of such an approach, and provide practice and future research guidelines as this elective procedure may not be ready for prime time just yet.